publication venue for

• Effectiveness of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccination Against SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 Lineage Hospitalization and a Comparison of Clinical Severity — IVY Network, 26 Hospitals, October 18, 2023–March 9, 2024 2024
• Availability of evidence and comparative effectiveness for surgical versus drug interventions: an overview of systematic reviews 2023
• Availability of evidence and comparative effectiveness for surgical versus drug interventions: an overview of systematic reviews 2023
• Sleep disturbance as a precursor to anxiety, depression, and PTSD among rural Kenyans: a cross-lagged panel analysis from a rural Kenyan interventional cohort 2023
• Trends in Pediatric Firearm-Related Encounters during the COVID-19 Pandemic by Age Group, Race/Ethnicity, and Schooling Mode in Tennessee 2023
• Assessing the effects of behavioral circadian rhythm disruption in shift-working police academy trainees 2021
• Clinical prediction rule for SARS-CoV-2 infection from 116 U.S. emergency departments 2021
• Clinical trial data sharing: A cross-sectional study of outcomes associated with two NIH models 2021
• Clinical trial data sharing: A cross-sectional study of outcomes associated with two NIH models 2021
• Effect of long-term caloric restriction on DNA methylation measures of biological aging in healthy adults: CALERIE™ trial analysis 2021
• U.S. Food and Drug Administration utilization of postmarketing requirements and postmarketing commitments, 2009-2018 2020
• U.S. Food and Drug Administration utilization of postmarketing requirements and postmarketing commitments, 2009-2018 2020
• Clinical trial evidence supporting FDA approval of novel therapeutic agents over three decades, 1995-2017: Cross-sectional analysis 2019
• Clinical trial evidence supporting FDA approval of novel therapeutic agents over three decades, 1995-2017: Cross-sectional analysis 2019
• Updating insights into rosiglitazone and cardiovascular risk through shared data: Individual patient- and summary-level meta-analyses 2019
• Updating insights into rosiglitazone and cardiovascular risk through shared data: Individual patient- and summary-level meta-analyses 2019